The Novel Functions of cGMP-Specific Phosphodiesterase 5 and its Inhibitors in Carcinoma Cells and Pulmonary/Cardiovascular Vessels

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|7|4|437-454

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.4, 2007-02, pp. : 437-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of a cGMP-specific phosphodiesterase inhibitor on retinal function

By Estrade M.   Grondin P.   Cluzel J.   Bonhomme B.   Doly M.  

European Journal of Pharmacology, Vol. 352, Iss. 2, 1998-07 ,pp. : 157-163

Elsevier

Access to resources Recommend Favorite

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5

By Silver P.J.   Pagani E.D.   Dundore R.L.   de Garavilla L.   Bode D.C.   Bacon E.R.  

European Journal of Pharmacology, Vol. 349, Iss. 2, 1998-05 ,pp. : 263-268

Elsevier

Access to resources Recommend Favorite

Cardiovascular Effects of Phosphodiesterase 5 Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3485-3494

Bentham Science Publishers

Access to resources Recommend Favorite

Factors contributing to differences in the regulation of cGMP in isolated porcine pulmonary vessels

By Bina S.   Hart J.L.   Sei Y.   Muldoon S.M.  

European Journal of Pharmacology, Vol. 351, Iss. 2, 1998-06 ,pp. : 253-260

Elsevier

Access to resources Recommend Favorite

Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication

By De LaVega Alfonso J   Derk Chris T  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 1, 2009-01 ,pp. : 23-29

Informa Healthcare

Access to resources Recommend Favorite